Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias

Journal of Molecular and Cellular Cardiology

Volumn 74, Issue , 2014, Pages 53-63

  Osbourne, Appledene ^a   Calway, Tyler ^a   Broman, Michael ^a   McSharry, Saoirse ^a   Earley, Judy ^a   Kim, Gene H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atrial arrhythmia; Connexin43; MicroRNA; Ventricular arrhythmia

Indexed keywords

CONNEXIN 43; MICRORNA; MICRORNA 130A; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HYBRID PROTEIN; LUCIFERASE; MIRN130 MICRORNA, HUMAN; MYOSIN HEAVY CHAIN; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; 3T3 CELL LINE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTROSTIMULATION; EMBRYO; FEMALE; GAP JUNCTION; GENE OVEREXPRESSION; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEART ARRHYTHMIA; HEART ATRIUM; HEART VENTRICLE; METABOLISM; PATHOLOGY; REPORTER GENE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ANIMALS; ARRHYTHMIAS, CARDIAC; CONNEXIN 43; FEMALE; GAP JUNCTIONS; GENE EXPRESSION REGULATION; GENES, REPORTER; HEART ATRIA; HEART VENTRICLES; LUCIFERASES; MICE; MICRORNAS; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; NIH 3T3 CELLS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84904743489     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.04.024     Document Type: Article

References (51)

1. Nattel S., Maguy A., Le Bouter S., Yeh Y.H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007, 87:425-456.
2. Peters N.S., Coromilas J., Severs N.J., Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997, 95:988-996.
3. Yao J.A., Hussain W., Patel P., Peters N.S., Boyden P.A., Wit A.L. Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ Res 2003, 92:437-443.
4. Kar R., Batra N., Riquelme M.A., Jiang J.X. Biological role of connexin intercellular channels and hemichannels. Arch Biochem Biophys 2012, 524:2-15.
5. Willecke K., Eiberger J., Degen J., Eckardt D., Romualdi A., Guldenagel M., et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002, 383:725-737.
6. Davis L.M., Rodefeld M.E., Green K., Beyer E.C., Saffitz J.E. Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol 1995, 6:813-822.
7. Gutstein D.E., Morley G.E., Tamaddon H., Vaidya D., Schneider M.D., Chen J., et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001, 88:333-339.
8. Kim G.H. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013, 161:381-392.
9. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
10. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
11. Jakob P., Doerries C., Briand S., Mocharla P., Krankel N., Besler C., et al. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 2012, 126:2962-2975.
12. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
13. Matkovich S.J., Van Booven D.J., Youker K.A., Torre-Amione G., Diwan A., Eschenbacher W.H., et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009, 119:1263-1271.
14. Kim G.H., Samant S.A., Earley J.U., Svensson E.C. Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One 2009, 4:e6161.
15. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998, 95:2979-2984.
16. Silahtaroglu A.N., Nolting D., Dyrskjot L., Berezikov E., Moller M., Tommerup N., et al. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2007, 2:2520-2528.
17. Westphal C., Spallek B., Konkel A., Marko L., Qadri F., DeGraff L.M., et al. CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy. PLoS One 2013, 8:e73490.
18. Ye L., Zhu W., Backx P.H., Cortez M.A., Wu J., Chow Y.H., et al. Arrhythmia and sudden death associated with elevated cardiac chloride channel activity. J Cell Mol Med 2011, 15:2307-2316.
19. Gutstein D.E., Danik S.B., Sereysky J.B., Morley G.E., Fishman G.I. Subdiaphragmatic murine electrophysiological studies: sequential determination of ventricular refractoriness and arrhythmia induction. Am J Physiol Heart Circ Physiol 2003, 285:H1091-H1096.
20. Vaidya D., Morley G.E., Samie F.H., Jalife J. Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 1999, 85:174-181.
21. Sanbe A.G.J., Hanks M.C., Liang Q., Osinska H., Robbins J. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 2003, 92:609-616.
22. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
23. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
24. Kertesz M., Iovino N., Unnerstall U., Gaul U., Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39:1278-1284.
25. Maragkakis M., Alexiou P., Papadopoulos G.L., Reczko M., Dalamagas T., Giannopoulos G., et al. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009, 10:295.
26. Remo B.F., Qu J., Volpicelli F.M., Giovannone S., Shin D., Lader J., et al. Phosphatase-resistant gap junctions inhibit pathological remodeling and prevent arrhythmias. Circ Res 2011, 108:1459-1466.
27. Houbaviy H.B., Murray M.F., Sharp P.A. Embryonic stem cell-specific microRNAs. Dev Cell 2003, 5:351-358.
28. Humphreys D.T., Hynes C.J., Patel H.R., Wei G.H., Cannon L., Fatkin D., et al. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. PLoS One 2012, 7:e30933.
29. Wu W.H., Hu C.P., Chen X.P., Zhang W.F., Li X.W., Xiong X.M., et al. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens 2011, 24:1087-1093.
30. Sepramaniam S., Ying L.K., Armugam A., Wintour E.M., Jeyaseelan K. MicroRNA-130a represses transcriptional activity of aquaporin 4 M1 promoter. J Biol Chem 2012, 287:12006-12015.
31. Tang L., Pu Y., Wong D.K., Liu T., Tang H., Xiang T., et al. The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai) 2011, 43:640-646.
32. Remo B.F., Giovannone S., Fishman G.I. Connexin43 cardiac gap junction remodeling: lessons from genetically engineered murine models. J Membr Biol 2012, 245:275-281.
33. Severs N.J., Bruce A.F., Dupont E., Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 2008, 80:9-19.
34. Igarashi T., Finet J.E., Takeuchi A., Fujino Y., Strom M., Greener I.D., et al. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation 2012, 125:216-225.
35. Luo M.H., Li Y.S., Yang K.P. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. Cardiology 2007, 107:248-253.
36. Thibodeau I.L., Xu J., Li Q., Liu G., Lam K., Veinot J.P., et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010, 122:236-244.
37. Thomas S.A., Schuessler R.B., Berul C.I., Beardslee M.A., Beyer E.C., Mendelsohn M.E., et al. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 1998, 97:686-691.
38. Temple I.P., Inada S., Dobrzynski H., Boyett M.R. Connexins and the atrioventricular node. Heart Rhythm 2013, 10:297-304.
39. Saiz J., Ferrero J.M., Monserrat M., Ferrero J.M., Thakor N.V. Influence of electrical coupling on early afterdepolarizations in ventricular myocytes. IEEE Trans Biomed Eng 1999, 46:138-147.
40. Gutstein D.E., Danik S.B., Lewitton S., France D., Liu F., Chen F.L., et al. Focal gap junction uncoupling and spontaneous ventricular ectopy. Am J Physiol Heart Circ Physiol 2005, 289:H1091-H1098.
41. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
42. Xu H.F., Ding Y.J., Shen Y.W., Xue A.M., Xu H.M., Luo C.L., et al. MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol Cell Biochem 2012, 362:141-148.
43. Danielson L.S., Park D.S., Rotllan N., Chamorro-Jorganes A., Guijarro M.V., Fernandez-Hernando C., et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J 2013, 27:1460-1467.
44. Beavers D.L., Wang W., Ather S., Voigt N., Garbino A., Dixit S.S., et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol 2013, 62:2010-2019.
45. Luo M., Anderson M.E. Mechanisms of altered Ca(2)(+) handling in heart failure. Circ Res 2013, 113:690-708.
46. Hong T.T., Smyth J.W., Gao D., Chu K.Y., Vogan J.M., Fong T.S., et al. BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol 2010, 8:e1000312.
47. Adam O., Lohfelm B., Thum T., Gupta S.K., Puhl S.L., Schafers H.J., et al. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol 2012, 107:278.
48. Belevych A.E., Sansom S.E., Terentyeva R., Ho H.T., Nishijima Y., Martin M.M., et al. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS One 2011, 6:e28324.
49. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
50. Lu Y., Zhang Y., Wang N., Pan Z., Gao X., Zhang F., et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010, 122:2378-2387.
51. Rau F., Freyermuth F., Fugier C., Villemin J.P., Fischer M.C., Jost B., et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 2011, 18:840-845.